Figure 3.

Application of the prediction models to predict pure risk of developing breast cancer recurrence in five years for hypothetical individuals with different risk profiles. A) predicted five-year risk of recurrence for HmR-positive (estrogen receptor–positive, progesterone receptor–positive, human epidermal growth factor receptor–negative) female breast cancer patients age 40 and 65 years. B) Predicted five-year risk of recurrence for triple-negative female breast cancer patients age 40 and 65 years. Error bars represent 95% confidence interval.